Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
Peter Kraft, Tobias Schwarz, Joost C. M. Meijers et al. · 2010
Read Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke by Peter Kraft, Tobias Schwarz, Joost C. M. Meijers et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011658.txt.
Description
Peter Kraft and co-authors studied a clotting regulator called TAFI in mice, in PLOS ONE in 2010. Clot formation is a key step in ischaemic stroke, when a clot blocks blood flow in the brain. Thrombin, a central clotting enzyme, also activates TAFI, which slows the breakdown of clots and makes them more stable.
Mice lacking TAFI might therefore have been expected to fare better. Instead, they proved susceptible to clots and ischaemic injury in the brain. The surprise vulnerability reveals a protective side to TAFI in cerebral blood flow that simple clot logic would not predict.
Catalog record
| CREATOR | Peter Kraft, Tobias Schwarz, Joost C. M. Meijers et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011658